Speaker Profile
Ph.D., Co-Founder & CTO, Resolute Bio
Biography
Maximilian Strauss works at the intersection of artificial intelligence and mass-spectrometry proteomics, where he co-founded and drives the technology behind a high-throughput spatial proteomics platform that turns human tissue into AI-ready molecular data. His focus is building the data engine and frontier AI models that learn across tissue images, the human proteome and drugs — working toward foundation models of biology — so medicines can be matched to the patients most likely to benefit.
He trained in mechanical engineering at the Technical University of Munich, with thesis research at Harvard's Wyss Institute, before doctoral research in physics on super-resolution imaging in Ralf Jungmann's lab at the Max Planck Institute. He completed a postdoc with Matthias Mann in Munich and Copenhagen and led bioinformatics at OmicEra Diagnostics (later acquired by Exact Sciences). He has also held a faculty position as an Assistant Professor in bioinformatics at the University of Copenhagen.
Talk
Molecular Intelligence: From Tissue to Treatment
The industry designs molecules; Resolute discovers who they work for. Going beyond DNA and RNA into the human spatial proteome, we combine computational pathology with mass spectrometry to learn the relationship between tissue and the proteome — building foundation models for trial selection and the next generation of precision medicine.
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2026 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
